Trial Profile
Comparison of efficacy of sitagliptin dose-up and that of glimepiride dose-up in Japanese subjects with type 2 diabetes inadequately controlled on combination therapy with sitagliptin and glimepiride
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Glimepiride (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Apr 2013 New trial record